iShares Biotechnology ETF (NASDAQ:IBB) Position Cut by Hanson & Doremus Investment Management

Hanson & Doremus Investment Management lowered its position in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 4.9% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 2,646 shares of the financial services provider’s stock after selling 135 shares during the period. Hanson & Doremus Investment Management’s holdings in iShares Biotechnology ETF were worth $350,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Huntington National Bank grew its position in iShares Biotechnology ETF by 17.9% in the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the last quarter. National Bank of Canada FI grew its holdings in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock worth $600,000 after buying an additional 229 shares in the last quarter. First Financial Bank Trust Division acquired a new stake in iShares Biotechnology ETF in the 3rd quarter valued at approximately $204,000. Thrive Wealth Management LLC bought a new stake in iShares Biotechnology ETF during the 3rd quarter valued at $445,000. Finally, Avior Wealth Management LLC boosted its position in iShares Biotechnology ETF by 438.2% during the 3rd quarter. Avior Wealth Management LLC now owns 3,229 shares of the financial services provider’s stock worth $470,000 after acquiring an additional 2,629 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

Shares of IBB opened at $137.49 on Thursday. The stock’s fifty day moving average is $136.30 and its 200-day moving average is $141.69. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently disclosed a dividend, which was paid on Friday, December 20th. Investors of record on Tuesday, December 17th were paid a dividend of $0.0624 per share. The ex-dividend date was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.